A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide

Original Article

A.M. Navar, E. Mikhailova, A.L. Catapano, P. Banka, D.J. Blom, A. Cadena, S. Kourpanidis, N.E. Lepor, K. Tsukamoto, G. Mendizabal, J. Nunez, W. Zhang, P. Zhu, M. Zhuo, and C.M. Ballantyne

N Engl J Med 2026;394:529-539

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
02/04/2026
Course expires: 
02/05/2028

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.